Central Pain Syndromes

Evidence-Based Chronic Pain Management

Volumn , Issue , 2010, Pages 267-278

  Svendsen, Kristina B ^a   Finnerup, Nanna B ^a   Klit, Henriette ^a   Jensen, Troels Staehelin ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Central pain in multiple sclerosis; Central pain syndromes; Central post stroke pain; Evidence based treatment of central pain; Pharmacologic intervention in CPSP; Pharmacologic intervention in MS associated CP; Quantitative sensory testing (QST); Side effects of commonly used drugs in central pain; Spinal cord injury pain; Subtypes of central pain conditions in MS

Indexed keywords

EID: 81855185704     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444314380.ch21     Document Type: Chapter

References (61)

1. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. IASP Press, Seattle, 1994.
2. Yezierski R.P. Pain following spinal cord injury: central mechanisms. In: Cer Does the cannabinoid dronabinol reduce central pain in multiple sclerosisero F, Jensen TS (eds) Handbook of Clinical Neurology: Pain. Elsevier, Amsterdam, 2006: 293-307.
3. Svendsen KB, Jensen TS, Hansen HJ, Bach F.W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005; 114: 473-481.
4. Andersen G, Vestergaard K, Ingeman NM, Jensen T.S. Incidence of central post-stroke pain. Pain 1995; 61: 187-193.
5. Finnerup NB, Jensen T.S. Spinal cord injury pain-mechanisms and treatment. Eur J Neurol 2004; 11: 73-82.
6. Pagni C.A. Central Pain-A Neurosurgical Challenge. Edizioni Minerva Medica, Turin, 1998.
7. Craig AD, Chen K, Bandy D, Reiman E.M. Thermosensory activation of insular cortex. Nat Neurosci 2000; 3: 184-190.
8. Bowsher D. Central pain: clinical and physiological characteristics. J Neurol Neurosurg Psychiatry 1996; 61: 62-69.
9. Boivie J. Central pain. In: McMahon SB, Koltzenburg M (eds) Textbook of Pain. Elsevier Churchill Livingstone, London, 2006: 1057-1074.
10. MacGowan DJ, Janal MN, Clark WC, et al. Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients. Neurology 1997; 49: 120-125.
11. Leijon G, Boivie J. Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine. Pain 1989; 36: 27-36.
12. Vestergaard K, Andersen G, Jensen T.S. Treatment of central post-stroke pain with a selective serotonin reuptake inhibitor. Eur J Neurol 1996; 3(suppl. 5): 169.
13. Vranken JH, Dijkgraaf MG, Kruis RM, van der Vegt MH, Hollmann MW, Heesen M. Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen. Pain 2008; 136(1-2): 150-157.
14. Vestergaard K, Andersen G, Gottrup H, Kristensen BT, Jensen T.S. Lamotrigine for central poststroke pain: a randomized controlled trial. Neurology 2001; 56: 184-190.
15. Lampl C, Yazdi K, Roper C. Amitriptyline in the prophylaxis of central poststroke pain. Preliminary results of 39 patients in a placebo-controlled, long-term study. Stroke 2002; 33: 3030-3032.
16. Rowbotham MC, Twilling L, Davies PS, Reisner L, Taylor K, Mohr D. Oral opioid therapy for chronic peripheral and central neuropathic pain. N Engl J Med 2003; 348: 1223-1232.
17. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127-133.
18. Siddall PJ, Finnerup N.B. Pain following spinal cord injury. In: Cervero F, Jensen TS (eds) Handbook of Clinical Neurology. Elsevier, Amsterdam, 2006: 689-703.
19. Siddall PJ, McClelland JM, Rutkowski SB, Cousins M.J. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 2003; 103: 249-257.
20. Werhagen L, Budh CN, Hultling C, Molander C. Neuropathic pain after traumatic spinal cord injury-relations to gender, spinal level, completeness, and age at the time of injury. Spinal Cord 2004; 42: 665-673.
21. Tai Q, Kirschblum S, Chen B, Millis S, Johnston M, DeLiza J.A. Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 2002; 25: 100-105.
22. Levendoglu F, Ogun CO, Ozerbil O, Ogun TC, Ugurlu H. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 2004; 29: 743-751.
23. Siddall PJ, Cousins MJ, Otte A, Griesing T, Chambers R, Murphy T.K. Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial. Neurology 2006; 67: 1792-1800.
24. Cardenas DD, Warms CA, Turner JA, Marshall H, Brooke MM, Loeser J.D. Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial. Pain 2002; 96: 365-373.
25. Davidoff G, Guarracini M, Roth E, Sliwa J, Yarkony G. Trazodone hydrochloride in the treatment of dysesthetic pain in traumatic myelopathy: a randomized, double-blind, placebo-controlled study. Pain 1987; 29:151-161.
26. Finnerup NB, Sindrup SH, Bach FW, Johannesen IL, Jensen T.S. Lamotrigine in spinal cord injury pain: a randomized controlled trial. Pain 2002; 96: 375-383.
27. Drewes AM, Andreasen A, Poulsen L.H. Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study. Paraplegia 1994; 32: 565-569.
28. Chiou-Tan FY, Tuel SM, Johnson JC, Priebe MM, Hirsh DD, Strayer J.R. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehabil 1996; 75: 84-87.
29. Siddall PJ, Molloy AR, Walker S, Rutkowski S.B. The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury. Anesth Analg 2000; 91: 1-6.
30. Österberg A, Boivie J, Thuomas K.A. Central pain in multiple sclerosis-prevalence and clinical characteristics. Eur J Pain 2005; 9: 531-542.
31. Jensen TS, Rasmussen P, Reske-Nielsen E. Association of trigeminal neuralgia with multiple sclerosis: clinical and pathological features. Acta Neurol Scand 1982; 65: 182-189.
32. Love S, Gradidge T, Coakham H.B. Trigeminal neuralgia due to multiple sclerosis: ultrastructural findings in trigeminal rhizotomy specimens. Neuropathol Appl Neurobiol 2001; 27: 238-244.
33. Smith KJ, McDonald W.I. The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philos Trans R Soc Lond B Biol Sci 1999; 354: 1649-1673.
34. Solaro C, Brichetto G, Amato MP, et al. The prevalence of pain in multiple sclerosis: a multicenter cross-sectional study. Neurology 2004; 63: 919-921.
35. Shibasaki H, Kuroiwa Y. Painful tonic seizure in multiple sclerosis. Arch Neurol 1974; 30: 47-51.
36. Spissu A, Cannas A, Ferrigno P, Pelaghi AE, Spissu M. Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov Disord 1999; 14: 331-335.
37. Moulin DE, Foley KM, Ebers G.C. Pain syndromes in multiple sclerosis. Neurology 1988; 38: 1830-1834.
38. Raminsky M. Hyperexcitability of pathologically myelinated axons and positive symptoms in multiple sclerosis. In: Waxman SG, Ritchie JM (eds) Demyelinating Disease: Basic and Clinical Electrophysiology. Raven Press, New York, 1981: 289-297.
39. Vermote R, Ketelaer P, Carton H. Pain in multiple sclerosis patients. A prospective study using the McGill Pain Questionnaire. Clin Neurol Neurosurg 1986; 88: 87-93.
40. Österberg A. Central pain in multiple sclerosis : clinical characteristics, sensory abnormalities and treatment. Linköping University, thesis, 2005; 903.
41. Attal N, Cruccu G, Haanpää M, et al. EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol 2006; 13: 1153-1169.
42. Lunardi G, Leandri M, Albano C, et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 1997; 48: 1714-1717.
43. Solaro C, Lunardi GL, Capello E, et al. An open-label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998; 51: 609-611.
44. Pollmann W, Feneberg W, Steinbrecher A, Haupts MR, Henze T. [Therapy of pain syndromes in multiple sclerosis-an overview with evidence-based recommendations]. Fortschr Neurol Psychiatr 2005; 73: 268-285.
45. Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999; 162: 162-168.
46. Rog DJ, Nurmikko TJ, Friede T, Young C.A. Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology 2005; 65: 812-819.
47. Houtchens MK, Richert JR, Sami A, Rose J.W. Open label gabapentin treatment for pain in multiple sclerosis. Mult Scler 1997; 3: 250-253.
48. Kalman S, Österberg A, Sorensen J, Boivie J, Bertler A.
49. Svendsen KB, Jensen TS, Bach F.W. Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomized double blind placebo controlled crossover trial, BMJ 2004; 329: 253.
50. Zajicek JP, Fox A, Sanders H, et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomized placebo-controlled trial. Lancet 2003; 362: 1517-1526.
51. Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether wholeplant cannabis extracts can improve intractable neurogenic symptoms. Clin Rehabil 2003; 17: 21-29.
52. Herman RM, D'Luzansky SC, Ippolito R. Intrathecal baclofen suppresses central pain in patients with spinal lesions. A pilot study. Clin J Pain 1992; 8: 338-345.
53. Semple DM, McIntosh AM, Lawrie S.M. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 2005; 19: 187-194.
54. Kalso E, Allan L, Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7: 381-386.
55. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005; 118: 289-305.
56. Andre-Obadia N, Peyron R, Mertens P, Mauguiere F, Laurent B, Garcia-Larrea L. Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy. Clin Neurophysiol 2006; 117: 1536-1544.
57. Fregni F, Boggio PS, Lima MC, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain 2006; 122: 197-209.
58. Gruccu G, Aziz TZ, Garcia-Larrea L, et al. EFNS guidelines on neurostimulation therapy for neuropathic pain. Eur J Neurology 2007; 14: 952-970.
59. Norrbrink Budh C, Kowalski J, Lundeberg T. A comprehensive pain management programme comprising educational, cognitive and behavioural interventions for neuropathic pain following spinal cord injury. J Rehabil Med 2006; 38: 172-180.
60. Gruccu G, Anand P, Attal N, et al. EFNS guidelines on neuropathic pain assessment. Eur J Neurol 2004; 11: 153-162.
61. Brainin M, Barnes M, Baron JC, et al. Guideline Standards Subcommittee of the EFNS Scientific Committee. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces-revised recommendations 2004. Eur J Neurol 2004; 11: 577-581.